Study Title and Description
Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
Key Questions Addressed
|4||Does treatment of bacterial vaginosis during pregnancy reduce preterm delivery and related morbidity and mortality? a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery? b) Does the effect of treatment vary by race/ethnicity? c) Does the effect of treatment vary by maternal age? d) Does the effect of treatment vary by gestational age? e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs, HIV status)?|
|5||What are the harms of treatment of bacterial vaginosis in pregnant adolescents and women? a) What are harms to pregnant adolescents and women? b) What are harms to the fetus or newborn?|
Primary Publication Information
|Title||Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.|
|Author||Subtil D., Brabant G., Tilloy E., Devos P., Canis F., Fruchart A., Bissinger MC., Dugimont JC., Nolf C., Hacot C., Gautier S., Chantrel J., Jousse M., Desseauve D., Plennevaux JL., Delaeter C., Deghilage S., Personne A., Joyez E., Guinard E., Kipnis E., Faure K., Grandbastien B., Ancel PY., Goffinet F., Dessein R.|
|Country||Pôle Femme Mère Nouveau-né, Centre Hospitalier Universitaire de Lille, Lille, France; Epidémiologie et Qualité des soins (EA 2694), Université de Lille, Lille, France.|
Pubmed ID: 30322724
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Study Data for this published project can be accessed from the SRDR Published Projects page, under the link in the Study Notes section of this project
Results & Comparisons
No Results found.